For a long time, researchers have proposed that sexual hormone, such as progesterone and estrogen, may play important roles in lung cancer carcinogenesis and development (27,28), which was supported by recent clinical findings of abnormal expression of ERβ (2–6) and increased intratumoral estrodial concentration in NSCLC tissues (8). The gene discussed is ESR2; the disease is non-small cell lung carcinoma.